Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
---|
12/02/1999 | WO1999061041A1 Novel peptides |
12/02/1999 | WO1999060986A2 Apoptosis modulators that interact with the huntington's disease gene |
12/02/1999 | WO1999060843A1 Transgenic plants producing a pap ii protein |
12/02/1999 | WO1999060842A2 Plant retroelements and methods related thereto |
12/02/1999 | WO1999060838A1 Organism and method for metal recovery, remediation and separation |
12/02/1999 | WO1999055564A8 Materials and methods for gene therapy |
12/02/1999 | WO1999053942A8 Compositions comprising osteoprotegerin for the prevention and treatment of cardiovascular diseases |
12/02/1999 | WO1999053091A9 Dna coding for gdnf, parts of said dna and gdnf variants |
12/02/1999 | WO1999053082A3 Hexose carrier proteins |
12/02/1999 | WO1999052941A3 Polypeptide domains capable of binding rho protein and their use in assays |
12/02/1999 | WO1999052548A3 Conjugate vaccines for the prevention of dental caries |
12/02/1999 | WO1999051745A3 Dna immunization against chlamydia infection |
12/02/1999 | WO1999051725A3 Assay for the diagnosis of schizophrenia based on a new peptide |
12/02/1999 | WO1999051268A9 Immunomodulatory compositions of mmtv antigens and methods of using same |
12/02/1999 | WO1999050424A3 Fusion protein comprising a sequence from a major coat protein of a papovavirus |
12/02/1999 | WO1999050413A3 Therapeutic applications of mature flint (mflint) polypeptides or opg3, a member of the tnf receptor superfamily |
12/02/1999 | WO1999050281A3 Collagen peptides and uses thereof |
12/02/1999 | WO1999049059A3 Methods of cancer diagnosis using a chimeric toxin |
12/02/1999 | WO1999048518A3 Medicament for preventing or treating papilloma virus-specific tumors |
12/02/1999 | WO1999046381A9 Human fgf gene and gene expression products |
12/02/1999 | WO1999045938B1 Thrombin preparation and products and fibrin sealant methods employing same |
12/02/1999 | WO1999043703A8 Method for immunochemically assaying anti-hm1.24 antibody |
12/02/1999 | WO1999043286A3 Isolated stromal cells for use in the treatment of diseases of the central nervous system |
12/02/1999 | WO1999040115A3 COMPOSITIONS AND METHODS TO INHIBIT FORMATION OF THE C5b-9 COMPLEX OF COMPLEMENT |
12/02/1999 | WO1999037661A9 Dna replication proteins of gram positive bacteria and their use to screen for chemical inhibitors |
12/02/1999 | WO1999035262A3 Apoptosis inducing molecule ii |
12/02/1999 | WO1999032634A3 Compositions derived from mycobacterium vaccae and methods for their use |
12/02/1999 | WO1999019354A9 Novel vitamin d receptor related polypeptides, nucleic acid sequence encoding the same and uses thereof |
12/02/1999 | DE19824230A1 Neues Endometriose-assoziiertes Gen Create an endometriosis-associated gene |
12/02/1999 | DE19823814A1 Verfahren zur Trennung und/oder Isolierung von Plasmaproteinen mit annularer Chromatographie A process for the separation and / or isolation of proteins with plasma of annular chromatography |
12/02/1999 | CA2745939A1 Mara family helix-turn-helix domains and their methods of use |
12/02/1999 | CA2745131A1 Aav5 vector and uses thereof |
12/02/1999 | CA2372411A1 Method for separating and/or isolating plasma proteins by annular chromatography |
12/02/1999 | CA2343317A1 Novel peptides |
12/02/1999 | CA2333592A1 Methods of inhibiting clot formation |
12/02/1999 | CA2333316A1 Method for separating and/or isolating plasma proteins by annularchromatography |
12/02/1999 | CA2333281A1 Carotenoid ketolase genes and gene products, production of ketocarotenoids and methods of modifying carotenoids using the genes |
12/02/1999 | CA2333167A1 Method for purification of borrelia lipoprotein ospa |
12/02/1999 | CA2333159A1 Method |
12/02/1999 | CA2333006A1 Calmodulin related protein |
12/02/1999 | CA2331833A1 Parasite antigens |
12/02/1999 | CA2329694A1 Kunitz domain polypeptide and materials and methods for making it |
12/02/1999 | CA2329525A1 Cytokine resistant cytomegalovirus promoter mutants and related products and methods |
12/02/1999 | CA2329506A1 Alg-2lp, alg-2 like molecules and uses therefor |
12/02/1999 | CA2329505A1 Recombinant aav vectors for gene therapy of hemophilia a |
12/02/1999 | CA2329274A1 Interleukin-21 |
12/02/1999 | CA2329269A1 Neisseria meningitidis antigenic polypeptides, corresponding polynucleotides and protective antibodies |
12/02/1999 | CA2329249A1 Apoptosis modulators that interact with the huntington's disease gene |
12/02/1999 | CA2329157A1 Inhibition of the binding of protein tyrosine phosphatase pest to domains of signalling proteins |
12/02/1999 | CA2329155A1 Interference with viral ires-mediated translation by a small yeast rna reveals critical rna-protein interactions |
12/02/1999 | CA2329150A1 Transgenic plants producing a pap ii protein |
12/02/1999 | CA2329143A1 Adeno-associated viral vector-mediated expression of factor viii activity |
12/02/1999 | CA2329136A1 Oral immunization with papillomavirus virus-like particles |
12/02/1999 | CA2329131A1 Method for recovering soluble protein |
12/02/1999 | CA2329072A1 Human transmembrane proteins |
12/02/1999 | CA2329056A1 Cell cycle genes, proteins and uses thereof |
12/02/1999 | CA2329053A1 Human socs proteins |
12/02/1999 | CA2329052A1 Canine and feline immunoregulatory proteins, nucleic acid molecules, and uses thereof |
12/02/1999 | CA2328905A1 Prostate growth-associated membrane proteins |
12/02/1999 | CA2328902A1 Novel secreted and membrane-associated proteins and uses therefor |
12/02/1999 | CA2328892A1 Tumor suppressor |
12/02/1999 | CA2328525A1 Modification of cereal grain hardness via expression of puroindoline proteins |
12/02/1999 | CA2328491A1 Retroviral delivery system |
12/02/1999 | CA2328451A1 Differential cytotoxicity of alternative forms of rotavirus nonstructural protein 4 |
12/02/1999 | CA2328134A1 The induction of antibiotic proteins and peptides by lait/scd14-protein |
12/02/1999 | CA2317697A1 Agent and method for modulation of cell migration |
12/02/1999 | CA2298070A1 Gene sequences of rubella virus associated with attenuation |
12/02/1999 | CA2234420A1 Methods for the detection, treatment, and prevention of neurodegeneration |
12/01/1999 | EP0960942A2 Targeted delivery through a cationic amino acid transporter |
12/01/1999 | EP0960941A1 Gene Therapy for cell proliferative diseases |
12/01/1999 | EP0960939A2 Dual-tagged proteins and their uses |
12/01/1999 | EP0960937A1 Novel semaphorin gene: semaphorin y |
12/01/1999 | EP0960935A1 Novel mouse cxc chemokine receptor |
12/01/1999 | EP0960888A1 Novel semaphorin genes (i) |
12/01/1999 | EP0960887A1 T cell epitope peptide |
12/01/1999 | EP0960886A1 Peptide T and related peptides in the treatment of inflammation, including multiple sclerosis |
12/01/1999 | EP0960339A1 Assay for collagen type ii fragments |
12/01/1999 | EP0960338A1 Diagnostic methods and compositions based on the distribution of rad51 |
12/01/1999 | EP0960336A1 Peptide reagent for the detection of human cytomegalovirus (cmv) |
12/01/1999 | EP0960335A2 Modulators of insulin receptor activity |
12/01/1999 | EP0960334A1 Vegf-b/receptor complex and uses thereof |
12/01/1999 | EP0960209A1 Editing-based selectable plastid marker genes |
12/01/1999 | EP0960205A1 Chain reaction cloning |
12/01/1999 | EP0960204A1 Method and reagents for genetic immunization |
12/01/1999 | EP0960202A1 Monocyte chemotactic protein 5 (mcp-5) molecules and uses therefor |
12/01/1999 | EP0960201A1 Mammalian ribonuclease inhibitors and use thereof |
12/01/1999 | EP0960200A1 Transcripts encoding immunomodulatory polypeptides |
12/01/1999 | EP0960199A2 Secreted proteins and polynucleotides encoding them |
12/01/1999 | EP0960198A1 Cd44-like protein |
12/01/1999 | EP0960197A1 GENES FROM 20q13 AMPLICON AND THEIR USES |
12/01/1999 | EP0960196A1 Novel receptor that causes cell death |
12/01/1999 | EP0960193A1 ISOLATION AND CLONING OF THE HUMAN hARSA-I GENE AND USES THEREOF |
12/01/1999 | EP0960191A1 Compositions and methods for use of defensin |
12/01/1999 | EP0960130A1 Oxygen-binding heme proteins incorporating circularly-permuted globins |
12/01/1999 | EP0960129A1 MELATONIN 1a RECEPTOR GENE REGULATORY REGIONS AND USES THEREOF |
12/01/1999 | EP0960128A1 Gene product over expressed in cancer cells |
12/01/1999 | EP0960127A1 Isolated dimeric fibroblast activation protein alpha, and uses thereof |
12/01/1999 | EP0960126A1 Compositions and uses for sentrin, a cell-death protecting protein |
12/01/1999 | EP0960125A1 GALANIN RECEPTOR GalR2 AND NUCLEOTIDES ENCODING SAME |
12/01/1999 | EP0960124A1 Serine substituted mutants of bcl-xl/bcl-2 associated cell death regulator |